Help Desk: http://www.ucl.ac.uk/ras/portico/helpdesk
- Professor of Cancer Biology
- Research Department of Cancer Bio
- Cancer Institute
- Faculty of Medical Sciences
Professor Walczak is the Head of Department of Cancer Biology and Scientific Director of the Cancer Research UK – UCL Centre at the UCL Cancer Insitute. He also chairs the Centre for Cell Death, Cancer and Inflammation (CCCI). His team, which is funded by Cancer Research UK, the Wellcome Trust and the European Research Council, is internationally recognised for its work on cell death and inflammation, specifically focussing on the biology of death receptor-ligand and the ubiquitin systems.
Following his PhD in 1995 at the German Cancer Research Centre (DKFZ) in Heidelberg (Germany), Professor Walczak worked as a postdoc at Immunex Corporation in Seattle (WA, USA), before returning to the DKFZ as group leader in 1998. In 2007 he was appointed Chair of Tumour Immunology at Imperial College.
The aims of Professor Walczak’s research are to develop new therapies for cancer on the basis of the concept of directly and specifically inducing programmed cell death in cancer cells and new therapeutic options for patients suffering from auto-immunity based on the concept that different forms of cell death differentially stimulate the immune system.